Revance Therapeutics: Q4 Earnings Insights

Revance Therapeutics RVNC reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Revance Therapeutics beat estimated earnings by 8.82%, reporting an EPS of $-0.93 versus an estimate of $-1.02.

Revenue was up $14.82 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.05 which was followed by a 5.03% increase in the share price the next day.

Here's a look at Revance Therapeutics's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.